X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TTK HEALTHCARE - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TTK HEALTHCARE NOVARTIS/
TTK HEALTHCARE
 
P/E (TTM) x 299.3 21.3 1,407.7% View Chart
P/BV x 33.2 7.2 463.8% View Chart
Dividend Yield % 1.4 0.4 339.2%  

Financials

 NOVARTIS   TTK HEALTHCARE
EQUITY SHARE DATA
    NOVARTIS
Mar-18
TTK HEALTHCARE
Mar-14
NOVARTIS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs758663 114.3%   
Low Rs579399 145.1%   
Sales per share (Unadj.) Rs228.4535.6 42.6%  
Earnings per share (Unadj.) Rs31.715.9 199.0%  
Cash flow per share (Unadj.) Rs32.820.0 163.6%  
Dividends per share (Unadj.) Rs10.004.00 250.0%  
Dividend yield (eoy) %1.50.8 198.7%  
Book value per share (Unadj.) Rs297.1137.6 215.9%  
Shares outstanding (eoy) m24.697.77 317.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.0 295.1%   
Avg P/E ratio x21.133.3 63.2%  
P/CF ratio (eoy) x20.426.5 76.9%  
Price / Book Value ratio x2.23.9 58.3%  
Dividend payout %31.525.1 125.6%   
Avg Mkt Cap Rs m16,5054,127 399.9%   
No. of employees `0000.71.7 39.1%   
Total wages/salary Rs m1,445607 238.3%   
Avg. sales/employee Rs Th8,441.32,436.7 346.4%   
Avg. wages/employee Rs Th2,163.6355.2 609.2%   
Avg. net profit/employee Rs Th1,173.172.5 1,617.1%   
INCOME DATA
Net Sales Rs m5,6394,162 135.5%  
Other income Rs m1,71861 2,807.7%   
Total revenues Rs m7,3574,223 174.2%   
Gross profit Rs m-63197 -31.7%  
Depreciation Rs m2532 79.8%   
Interest Rs m5530 184.9%   
Profit before tax Rs m1,575197 800.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m79273 1,087.4%   
Profit after tax Rs m784124 632.4%  
Gross profit margin %-1.14.7 -23.4%  
Effective tax rate %50.337.0 135.8%   
Net profit margin %13.93.0 466.8%  
BALANCE SHEET DATA
Current assets Rs m9,5221,629 584.6%   
Current liabilities Rs m3,2961,058 311.6%   
Net working cap to sales %110.413.7 804.8%  
Current ratio x2.91.5 187.6%  
Inventory Days Days3730 123.0%  
Debtors Days Days2834 84.6%  
Net fixed assets Rs m46556 8.3%   
Share capital Rs m12378 158.8%   
"Free" reserves Rs m7,213878 821.2%   
Net worth Rs m7,3361,069 686.1%   
Long term debt Rs m0159 0.0%   
Total assets Rs m11,1052,399 462.8%  
Interest coverage x29.57.6 389.1%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.51.7 29.3%   
Return on assets %7.66.4 117.9%  
Return on equity %10.711.6 92.2%  
Return on capital %22.218.5 120.4%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m6133 184.2%   
Fx outflow Rs m3,63063 5,744.9%   
Net fx Rs m-3,570-30 11,784.7%   
CASH FLOW
From Operations Rs m1,610127 1,271.6%  
From Investments Rs m687-146 -470.5%  
From Financial Activity Rs m-2,67722 -12,221.5%  
Net Cashflow Rs m-3803 -15,184.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 3.7 54.1%  
FIIs % 1.6 5.2 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.8 83.3%  
Shareholders   41,647 12,723 327.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets End Lower; Metal Stocks Top Losers(Closing)

Indian share markets settled lower today led by a fall in the financial stocks after the rupee hit a record low of 70.32 per dollar.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY19); Net Profit Up 42.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, NOVARTIS has posted a net profit of Rs 100 m (up 42.2% YoY). Sales on the other hand came in at Rs 1 bn (up 20.3% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 16, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS